Jacco J. de Haan, MD, PhD

University Medical Center Groningen
Groningen, Groningen, Netherlands

Presentation(s):

• Paper 31 - THE TETRAVALENT DEATH RECEPTOR 5 AGONIST OZEKIBART (INBRX-109) IN CHONDROSARCOMA: RESULTS FROM THE RANDOMIZED, REGISTRATIONAL, PHASE 2 CHONDRAGON STUDY

  Friday, November 14, 2025
  8:30 AM - 10:00 AM EST

  Disclosure information not submitted.

• Paper 51 - HEALTH-RELATED QUALITY OF LIFE IN PATIENTS WITH A HEAD AND NECK SARCOMA: A MIXED-METHODS STUDY

  Friday, November 14, 2025
  4:00 PM - 5:00 PM EST

  Disclosure information not submitted.